approval
saveELELYSO (TALIGLUCERASE ALFA) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: POWDER. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalDec 22, 2025 · 286d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalJan 17, 2025 · 625d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalJul 10, 2024 · 816d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalMay 9, 2023 · 1244d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalAug 30, 2022 · 1496d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalNov 3, 2020 · 2161d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalOct 21, 2019 · 2540d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalDec 20, 2016 · 3575d ago
same company · ±60 days · 6
- approvaltaliglucerase alfa: ELELYSO (TALIGLUCERASE ALFA) — FDA approvalAug 27, 2014
- approvalCLEOCIN: CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approvalAug 29, 2014
- approvalestradiol ER: ESTRING (ESTRADIOL) — FDA approvalAug 12, 2014
- approvalCLEOCIN: CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approvalSep 18, 2014
- approvalCLEOCIN: CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approvalOct 20, 2014
- approvalMETHYLPREDNISOLONE ACETATE: DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalJul 3, 2014
comments(0)
5-min edit window · permanent after that